MCK
McKesson Corporation
NYSE: MCK · HEALTHCARE · MEDICAL DISTRIBUTION
$725.17
+2.47% today
Updated 2026-06-05
Market cap
$91.29B
P/E ratio
20.32
P/S ratio
0.23x
EPS (TTM)
$38.37
Dividend yield
0.40%
52W range
$634 – $998
Volume
1.1M
WallStSmart proprietary scores
53
out of 100
Grade: C
Hold
Investment rating
8.0
Growth
A7.0
Quality
B+4.5
Profitability
C4.0
Valuation
C5/9
Piotroski F-Score
Moderate
5.4
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$930.00
+28.25%
12-Month target
$885.45
+22.10%
Intrinsic (DCF)
$576.90
Margin of safety
-65.23%
4 Strong Buy11 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 5.40 — safe zone
+ Free cash flow $3.31B — positive
+ Debt/equity -3.97x — low leverage
Risks
- Thin margins at 1.18%
- 65.23% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM | 2027 (E) |
|---|---|---|---|---|---|---|
| Revenue | $276.71B | $308.95B | $359.05B | $403.43B | $403.43B | $446.6B |
| Net income | $3.56B | $3.00B | $3.29B | $4.76B | $1.68B | — |
| EPS | — | — | — | — | $38.37 | $44.69 |
| Free cash flow | $4.60B | $3.63B | $5.23B | $5.72B | $3.31B | — |
| Profit margin | 1.29% | 0.97% | 0.92% | 1.18% | 1.18% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-09 | TYLER, BRIAN S. | Sale | 4,929 | $763.00 |
| 2026-06-05 | RUTLEDGE, NAPOLEON B JR | Sale | 133 | $764.00 |
| 2026-06-02 | RODGERS, THOMAS L | Sale | 699 | $735.27 |
Peer comparison
Smart narrative
McKesson Corporation trades at $725.17. representing a P/E of 20.32x trailing earnings. Our Smart Value Score of 53/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 5.40, it sits in the safe zone. TTM revenue stands at $403.43B. with profit margins at 1.18%. Our DCF model estimates intrinsic value at $576.90.
Frequently asked questions
What is McKesson Corporation's stock price?
McKesson Corporation (MCK) trades at $725.17, on a P/E of 20.3x and a P/S of 0.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is McKesson Corporation overvalued?
McKesson Corporation carries a Smart Value Score of 53/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $576.90 against the $725.17 price, so on cash flow terms the market is paying a premium for McKesson Corporation's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of McKesson Corporation (MCK)?
The 12-month analyst consensus target is $930.00, about 28.2% above the current $725.17. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of MCK by 2030?
Our research-backed model puts the 2030 base case at $55,621.21, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of McKesson Corporation (MCK)?
Our DCF model estimates intrinsic value at $576.90, a -65.2% margin of safety versus today's $725.17. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is McKesson Corporation's revenue?
McKesson Corporation's trailing twelve-month revenue is $403.43B, and our model projects it reaching about $564.00B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
McKesson Corporation's Altman Z-Score is 5.40, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DISTRIBUTION
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.23x
ROE—
Beta0.32
50D MA$795.55
200D MA$822.91
Shares out0.12B
Float0.12B
Short ratio—
Avg volume1.1M
Performance
1 week+0.00%
1 month+2.89%
3 months-12.34%
YTD-5.44%
1 year—
3 years—
5 years—